Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients
✍ Scribed by Rafael Molina; Gabriel Zanón; Xavier Filella; Ferran Moreno; Judith Jo; Montserrat Daniels; Maria L. Latre; Nuria Giménez; Jaume Pahisa; Martín Velasco; Antonio M. Ballesta
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Weight
- 692 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The CA 15-3 and CEA concentrations and the alkaline phosphatase (ALP) and y-glutamyl transferase (Gamma GT) activities of serum from 78 patients with breast cancer have been measured. The patients included 27 with localised breast cancer, 19 who had been treated for breast cancer but were now diseas
Monthly serial postoperative CEA determinations, three-monthly system review plus physical examination, and a battery of six-monthly laboratory and radiologic tests were compared in order to evaluate each in detection of recurrent colorectal cancer. Twelve of the 33 patients studied prospectively de
## BACKGROUND. The differential diagnosis of pleural effusion is a frequent clinical problem. Several tumor markers have been evaluated in pleural fluid, but the value of CA 72-4 assay and of combinations of tumor marker assays has not been firmly established. To find a minimally invasive tool for
Vascular endothelial growth factor (VEGF), tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) were measured in 314 sera of breast cancer patients and in 58 sera of women without breast cancer. VEGF was determined using a sandwich enzyme immunoassay tec